Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1

Pediatric Infectious Disease Journal

Volumn 25, Issue 4, 2006, Pages 368-370

  Armenian, Saro H ^a,b   Jin, Young Han ^a,b   Dunaway, Theresa M ^a,b   Church, Joseph A ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Chickenpox; Human immunodeficiency virus type 1; Varicella virus vaccine

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CHICKENPOX; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MALAISE; MALE; PAPULE; PRIORITY JOURNAL; SKIN INDURATION; TREATMENT OUTCOME; VIRUS LOAD;

CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; HERPESVIRUS 3, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; INFANT; VACCINATION;

EID: 33645546249     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000207492.97867.15     Document Type: Article

References (10)

1. Derryck A, LaRussa P, Steinberg S, et al. Varicella and zoster in children with human immunodeficiency virus infection. Pediatr Infect Dis J. 1998;17:931-933.
2. Srugo I, Israele V, Wittek AAE, et al. Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children. AJDC. 1993;147:742-745.
3. Ferdman RM, Church JA. Failure of intravenous immunoglobulin to prevent varicella-zoster infection. Pediatr Infect Dis J. 2000;19:1219-1220.
4. Vazquez M, LaRussa PS, Gershon AA, et al. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med. 2001;344:955-960.
5. Levin MJ, Gershon AA, Weinberg A, et al. Immunization of HIV-infected children with varicella vaccine. J Pediatr. 2001;139:305-310.
6. Peterson J, Church J, Gomperts E, et al. Lymphocyte phenotype does not predict immune function in pediatric patients infected with human immunodeficiency virus type 1. J Pediatr. 1989;115:944-948.
7. Chartrand SA. Varicella vaccine. Pediatr Clin North Am. 2000;47:373-394.
8. Rousseau MC, Moreau J, Delmont J. Vaccination and HIV: a review of the literature. Vaccine. 2000;18:825-831.
9. Arvin AM. Immune responses to varicella-zoster virus. Infect Dis Clin North Am. 1996;10:529-570.
10. Weinberg A, Wizina AA, LaFleur BK, et al. Varicella-zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis. 2004;190:267-270.